Welcome to our spotlight session. Today, it's all about QuantiFERON. And in the next hour, you will learn more about our strategic priorities and the latest developments. But before we start, let's ...
Liver fibrosis may be diagnosed and staged — no fibrosis (stage F0), mild fibrosis (F1), significant fibrosis (F2), advanced fibrosis (F3), and cirrhosis (F4) — with the use of clinical parameters and ...
eCRC “A. M. and A. Migliavacca” Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy fDepartment of Internal Medicine, College of Medicine, ...
10 Centre for the Aids Programme of Research in South Africa (CAPRISA), Durban, South Africa Introduction HIV drug resistance poses a challenge to the United Nation’s goal of ending the HIV/AIDS ...
The HIV-1 envelope glycoprotein (Env) is the sole neutralizing determinant on the surface of the virus. The Env gp120 and gp41 subunits mediate receptor binding and membrane fusion and are generated ...
Retinoic acid-inducible gene I (RIG-I) is essential for activating host cell innate immunity to regulate the immune response against many RNA viruses. We previously identified that a small molecule ...
A simple test using a swab of cells from the inside of your cheek can dramatically improve your medical treatment. The test can predict whether a drug will help, if you need a different dosage, or if ...
Interruption of combination antiretroviral therapy (ART) in HIV-1-infected individuals leads to rapid viral rebound. Here we report the results of a phase IIa open label clinical trial evaluating ...
fDivision of Respiratory Medicine and Stanley Ho Center for emerging Infectious Diseases, The Chinese University of Hong Kong, Prince of Wales Hospital, New Territories, Hong Kong gTherapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results